Cardiology

Pregnancies with mechanical heart valves carry high risks, as a global registry reveals stark outcomes.

Rising systolic blood pressure variability increases risks of heart disease, kidney disease, and death.

Blood pressure control over 48 months cuts dementia risk by 15% in a large clinical trial.

Clinical trial results reveal that etripamil cuts emergency department visits by 39% inpatients with paroxysmal supraventricular tachycardia.

Early GDMT goals, especially blood pressure control, reduce the risk of CV events in chronic coronary disease.

New study shows all ADHD medications, not just stimulants, affect cardiovascular parameters in children, adolescents, and adults.

Wearable ECG shirt monitors heart rate recovery, predicting cardiovascular risk with 86% accuracy in new study.

Research reveals that hypertensive pregnancy disorders double dilated cardiomyopathy risk; highlighting that vigilance is needed postpartum.

Genetic study with 796,722 participants reveals that remnant cholesterol drives PAD risk independently.

Discover how 60 genes drive congenital heart disease. Learn how genetic testing improves outcomes.

OAC discontinuation post-catheter ablation for AF reduces bleeding but increases thromboembolic risk.

A new study shows that compound heatwaves drive linear cardiac mortality risks, surpassing daytime/night-only events.

New research shows how the FAB Score predicts mortality risk in adult Fontan patients with 92% accuracy.

Machine learning model predicts death risk in broken heart syndrome with 84% accuracy, a new study reveals.

Novel metabolic accelerator HU6 reduces fat mass without muscle loss in obesity-related heart failure patients.

Research suggests statins significantly reduce liver cancer and decompensation risk in chronic liver disease patients, especially with prolonged use.

Quitting alcohol raises bad cholesterol while lowering good cholesterol, study finds.

SCAD study flags risky blood thinners, fibromuscular dysplasia as predictors of heart complications. Urges treatment rethink.

Butter linked to higher mortality; plant-based oils reduce death risks. Study urges dietary swaps for long-term health.

Long-term study reveals alarming cardiovascular risks in steroid users, with some heart conditions up to nine times more likely.

Study finds no increased risk of major cardiovascular events with nicotinamide use but highlights risks for prior MACE patients.

Arterial stiffness, measured by pulse wave velocity, is more strongly linked to ageing than short-term blood pressure variability.

New study finds the PERIXa protocol for perioperative anticoagulation in AF patients undergoing low-risk procedures is safe.

Myocardial fibrosis predicts mortality after aortic valve replacement, highlighting its importance for risk assessment in aortic stenosis.

A groundbreaking study from the European Society of Cardiology suggests that pregnancy in women with peri-partum cardiomyopathy (PPCM) may not be as high-risk as previously believed.

Tirzepatide reduces LV mass and paracardiac fat in obesity-related HFpEF, offering structural heart benefits beyond weight loss.

Olpasiran significantly lowers oxidized phospholipids on apolipoprotein B but has no impact on systemic inflammatory markers in cardiovascular disease.

Minimally invasive endoscopic ultrasound-guided radiofrequency ablation offers a safe and effective alternative to adrenalectomy for treating unilateral aldosterone-producing adenomas.

A large Spanish cohort study highlights the distinct clinical features, management, and outcomes of coagulase-negative staphylococcal endocarditis.

Study reveals distinct clinical features in patients with both cardiac sarcoidosis and ACM-associated genetic variants, aiding diagnosis.

Younger patients with hypertrophic cardiomyopathy face increased sudden cardiac death risk during high-intensity exercise, despite no link to traditional risk factors.

A novel cardiovascular risk score improves prediction of heart disease by assessing stress-related changes in vascular function.

The 2025 AHA report highlights ongoing disparities in cardiovascular health, urging clinicians to enhance prevention and early intervention efforts.

Engineered heart muscle allografts safely remuscularize failing hearts, showing promise for heart failure treatment in primates and humans.

Women with permanent atrial fibrillation face a higher risk of heart failure than men, highlighting sex-specific risk factors.

Discover AROSE, a new equation to better predict ASCVD risk in individuals with obesity, outperforming current models.

Reduced placental flow and malperfusion defects in fetuses with CHD highlight potential pathways impacting growth and outcomes.

PTSD worsens endothelial function in women with HIV, a key cardiovascular risk factor. Early screening could improve outcomes.

Small heart size increases mortality risk in normal ejection fraction individuals, especially women and high-normal LVEF patients.

AI model automates heart failure identification, offering precision and paving the way for improved quality assessments.

Echocardiographic donor heart size matching improves heart transplant outcomes, outperforming traditional methods, especially for obese recipients.

Aspirin avoidance in patients with HeartMate 3 LVAD reduces bleeding risk without increasing thrombosis, even with vascular conditions.

Pregnancy does not increase long-term risks of mortality or adverse outcomes in individuals with hypertrophic cardiomyopathy.

Tafamidis reduces mortality and slows cardiac deterioration in ATTR-CM, improving imaging and clinical outcomes.

Study finds anti-CGRP mAbs do not increase cardiovascular risk in older or disabled patients with migraine.

Study links type 2 diabetes to impaired fibrous repair in atherosclerotic plaques, highlighting new treatment possibilities.

AI-enhanced ECG predicts hypertension and identifies patients at risk for adverse events, transforming preventive care approaches.

Chronic air pollution exposure significantly raises the risk of venous thromboembolism, underscoring its health impacts and clinical relevance.

AAS use may cause persistent coronary microvascular dysfunction, even years after cessation, highlighting long-term cardiovascular risks.

Aficamten improves symptoms, biomarkers, and quality of life in nonobstructive hypertrophic cardiomyopathy, promising better treatment options.

Exploring how cardiovascular imaging can better address the unique risks and outcomes of heart disease in women.

Plozasiran significantly reduced triglycerides by 57% in severe hypertriglyceridemia, showing promise as a new treatment option.

New triple single-pill treatment lowers BP effectively and safely, simplifying early hypertension management in clinical practice.

Using heart age to guide treatment decisions could lead to inappropriate care, impacting both younger and older patients.

NT-proBNP strongly predicts atrial fibrillation risk, particularly in older adults, with implications for improved risk stratification.

Cardiac MRI reveals key risk factors for sudden cardiac events in Fontan patients, potentially guiding better clinical care.

Seasonal flu increases deaths and hospitalisations in heart failure patients, stressing the need for enhanced prevention.

Systematic review finds no increased intracranial haemorrhage risk with DOACs versus antiplatelets, reinforcing atrial fibrillation guidelines.

LGE imaging predicts sudden cardiac death in young HCM patients, improving risk models and informing clinical strategies.

Glycemic control influences brain connectivity and heart variability, with distinct age and sex differences in healthy adults.

VO2peak declines in Fabry disease, correlating with cardiomyopathy severity, suggesting its use as a marker for therapy response.

Novel study links coronary microvascular dysfunction to increased atherosclerotic plaque burden in INOCA, advancing cardiovascular insights.

Evolocumab improves endothelial function in cardiovascular patients, suggesting potential long-term benefits for heart health.

Stress echocardiography predicts five-year cardiovascular risk, guiding treatment for high-risk patients and offering reassurance for low-risk cases.